Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone
Authors:
- S BordSBS Bord
- A HornerAHA Horner
- C.A BeetonCBC.A Beeton
- R.M HembryRHR.M Hembry
- J.E CompstonJCJ.E Compston
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Stromelysin-1 (MMP-3) and Stromelysin-2 (MMP-10) Expression in Developing Human Bone: Potential Roles in Skeletal DevelopmentBone, 1998
- Association between Ratio of Matrix Metalloproteinase-1 to Tissue Inhibitor of Metalloproteinase-1 and Local Recurrence, Metastasis, and Survival in Human Chondrosarcoma*Journal of Bone and Joint Surgery, 1998
- Production of collagenase by human osteoblasts and osteoclasts in vivoBone, 1996
- Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: An in vitro and ex vivo study of remodeling boneJournal of Bone and Mineral Research, 1995
- Fluctuation of mineral apposition rate at individual bone-remodeling sites in human iliac cancellous bone: Independent correlations with osteoid width and osteoblastic alkaline phosphatase activityJournal of Bone and Mineral Research, 1994
- The Prevention of Collagen Breakdown in Bovine Nasal Cartilage by TIMP, TIMP-2 and a Low Molecular Weight Synthetic InhibitorBiochemical and Biophysical Research Communications, 1994
- cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases.Proceedings of the National Academy of Sciences, 1990
- Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.Journal of Clinical Investigation, 1989
- Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activityNature, 1985
- The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritisRheumatology International, 1981